Electroconvulsive therapy in Parkinson's disease and other movement disorders

Movement Disorders

Volumn 6, Issue 4, 1991, Pages 293-303

  Faber, Raymond ^a   Trimble, Michael R ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Electroconvulsive therapy; Movement disorders; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE;

ELECTROCONVULSIVE THERAPY; HUMAN; PARKINSON DISEASE; REVIEW; TARDIVE DYSKINESIA;

DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DEPRESSIVE DISORDER; DOMINANCE, CEREBRAL; DYSKINESIA, DRUG-INDUCED; ELECTROCONVULSIVE THERAPY; HUMAN; MOVEMENT DISORDERS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE;

EID: 0025933802     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870060405     Document Type: Review

References (94)

1. Electric convulsive therapy in geriatrics
2. Observations of the effect of electroshock treatment on patients with parkinsonism
3. Die Electrokrampfbehandlung in ihrer Beziehung zur Neurologie
4. Electroshock therapy in patients with severe organic disease
5. Electroshock in the presence of organic disease of the central nervous system
6. Electroconvulsive therapy in patients with structural disease of the central nervous system
7. Electroconvulsive therapy in elderly patients
8. Electric shock treatment
9. Electroconvulsive treatment in a general hospital
10. Improvement of parkinsonism in depressed patients treated with ECT
11. Electroconvulsive therapy in patients with parkinsonism
12. Parkinsonism, depression and ECT
13. Parkinsonism, depression and ECT
14. Parkinsonism masked by ECT and psychotropic medication
15. Improvements of depression and parkinsonism during ECT
16. Parkinson's disease, depression, and ECT: a review and case study
17. Cuadros depresivos en enfermedad de Parkinson tratados con electroshock
18. Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurological synthesis
19. Parkinsonism: improvement by electroconvulsive therapy
20. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems
21. Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT
22. Covariation of depressive symptoms, parkinsonism, and post‐dexamethasone plasma cortical levels in bipolar patients: simultaneous response to ECT and lithium carbonate
23. Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease
24. Electroconvulsive therapy in parkinsonism with affective disorder
25. Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy
26. Electroconvulsive therapy in a patient with mania, parkinsonism, and tardive dyskinesia
27. Parkinson's disease revisited: a “naturalistic” study
28. Electroconvulsive therapy in Parkinson's syndrome with “on‐off” phenomenon
29. Predictors for improvement after electroconvulsive therapy in a parkinsonian patient with “on‐off” symptoms
30. Electroconvulsive therapy in parkinsonian patients with the “on‐off” syndrome
31. A double‐blind evaluation of electroconvulsive therapy in Parkinson's disease with “on‐off” phenomena
32. The use of ECT for parkinson symptoms in a nondepressed patient
33. Amelioration of druginduced parkinsonism by ECT
34. ECT combined with neuroleptics in the treatment of schizophrenia
35. ECT and drug‐induced parkinsonism
36. Electronconvulsive therapy in neuropeptic‐induced parkinsonism
37. ECT and tardive dyskinesia
38. A single‐blind study of ECT in patients with tardive dyskinesia
39. The effects of electroconvulsive therapy on tardive dyskinesia
40. Treatment of tardive dyskinesia in an agitated, depressed patient
41. ECT and tardive dyskinesia: two cases and a review
42. Improvement of tardive dyskinesia associated with electroconvulsive therapy
43. Tardive dyskinesia and electroconvulsive therapy
44. Absence of severe tardive dyskinesia in Hungarian schizophrenic outpatients
45. A study of facial dyskinesia in a mental hospital population
46. Reversible and irreversible dyskinesia after treatment with perphenazine, chloropromazine, reserpine, and electroconvulsive therapy
47. ECT, emergent dyskinesia, and depression
48. Tardive dystonia, catatonia, and electroconvulsive therapy
49. Temporary remission of tardive dystonia following electroconvulsive therapy
50. Tardive dystonia in a psychiatric hospital
51. Gilles de la Tourette's syndrome–symptom onset at age thirtyfive
52. Electroconvulsive therapy in one child and three adolescents
53. Electroconvulsive therapy in a patient with severe tic and major depressive episode
54. Post‐ECT asterixis associated with primary hyperparathyroidism
55. A mechanism for the efficiency of ECT in Parkinson's disease
56. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat straitum: an in vivo microdialysis study
57. Increased responsiveness of dopamine receptors after ECT: a review of experimental and clinical evidence
58. Psychopharmacology of repeated seizures: possible relevance to the mechanism of action of electroconvulsive therapy
59. Neurochemical and other consequences of ECT. Implications for the pathogenesis and treatment of affective disorders
60. Electroconvulsive therapy and the brain: evidence for increased dopamine‐mediated responses
61. Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment
62. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional ability of brain 5‐hydroxytryptamine and dopamine
63. Repeated electroconvulsive shock increases the behavioral responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens
64. Repeated electroconvulsive shock (ECS) enhances striated D‐1 dopamine receptor turnover in rats
65. The effects of electroconvulsive shock on dopamine‐1 and dopamine‐2 receptor ligand binding activity in MPTP‐treated mice
66. Repeated ECS enhances dopamine D‐1 but not D‐1 agonist–induced behavioral responses in rats
67. Chronic electroconvulsive shock increases D‐1 receptor binding in rat substrantia nigra
68. Pet scanning in dystonia
69. Chronic treatment with antidepressants decreases the number of 3H‐SCH23390 binding sites in the rat striatum and limbic system
70. Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain
71. Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters
72. Receptors and mechanism of action of electroconvulsive therapy
73. On the mechanism of potentiation of apomorphine‐induced stereotypy due to electroconvulsive shock
74. Clinical importance of D‐1 and D‐2 receptors
75. Review: D1 dopamine receptor–the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
76. Biochemical properties of CNS dopamine receptors
77. Electroconvulsive shock and dopamine neurotransmission [Abstract]
78. Biochemistry of neurotransmitters in Parkinson's disease
79. Adrenergic receptors in Parkinson's disease
80. The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical beta‐adrenoreceptors
81. Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine activated behaviours following repeated electroconvulsive shock
82. Implications of GABAergic synapses in neuropsychiatry
83. 3H SCH23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine
84. Increased 5‐HT receptor number in the brain as a probable explanation for the enhanced 5‐hydroxytryptamine‐mediated behaviour following repeated electroconvulsive shock administration to rats
85. Mechanism of the antidepressant action of electroconvulsive therapy
86. Neurochemical mechanisms of mood stabilization: focus on electroconvulsive therapy
87. Clinical strategies for evaluating electroconvulsive therapy mechanisms–pharmacological, biochemical and psychophysiological approaches
88. Opiate‐like effects of electroconvulsive shock in rats: a differential effect on nociceptive measures
89. Reduction of post‐ECT memory complaints through brief, partial restricted environmental stimulation
90. ECT for Parkinson's disease?
91. Prospective electroconvulsive therapy in a delusional depressed patient with a frontal meningioma